Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Alzheimer Disease × Rosiglitazone × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Alzheimer Disease 1

Interventions

Electroencephalography 2 UE2343 1 Tablets 1 Standard of Care 1 Rosiglitazone 1 Positron-Emission Tomography 1 Hormones 1 Exercise 1 Drug Delivery Systems 1 Donepezil 1 Blood Specimen Collection 1 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00428090 2017-05-19

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

GlaxoSmithKline

Phase 3 Completed

862 enrolled 36 charts

Alzheimer Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡